Evidence map›Paper›PMID 39453209›Full record

ArticleToxins2024

Antiproliferative Effects of

Yasmine Boughanmi, Caroline Berenguer-Daizé, Marielle Balzano, Hend Mosrati, Maxime Moulard, Pascal Mansuelle, Patrick Fourquet, Franck Torre, Harold de Pomyers, Didier Gigmes and 2 more

Abstract read
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yasmine BoughanmiAix Marseille University, Institut de Chimie Radicalaire UMR 7273, 13397 Marseille, France.
Caroline Berenguer-DaizéAix-Marseille University, INP-Institute of Neuropathophysiology-UMR 7051 CNRS, 13005 Marseille, France.
Marielle BalzanoBioCytex 140 Chemin de l'Armée d'Afrique, 13010 Marseille, France.
Hend MosratiAix Marseille University, Institut de Chimie Radicalaire UMR 7273, 13397 Marseille, France.
Maxime MoulardBioCytex 140 Chemin de l'Armée d'Afrique, 13010 Marseille, France.
Pascal MansuelleProteomics Platform, Marseille Proteomics (MaP), Institut de Microbiologie de la Méditerranée (IMM), FR 3479, CNRS, 13009 Marseille, France.ORCID 0000-0002-4504-6809
Patrick FourquetAix-Marseille University, INSERM, CNRS, Institut Paoli-Calmettes, CRCM, Marseille Proteomics, 13009 Marseille, France.ORCID 0000-0002-5547-0240
Franck TorreAix-Marseille University, Institut Méditerranéen de Biodiversité et d'Ecologie (IMBE), Avignon University, CNRS, IRD, 13397 Marseille, France.
Harold de PomyersLatoxan, 26800 Portes-lès-Valence, France.
Didier GigmesAix Marseille University, Institut de Chimie Radicalaire UMR 7273, 13397 Marseille, France.
Lhoucine OuafikAix-Marseille University, INP-Institute of Neuropathophysiology-UMR 7051 CNRS, 13005 Marseille, France.ORCID 0000-0002-4848-1232
Kamel MabroukAix Marseille University, Institut de Chimie Radicalaire UMR 7273, 13397 Marseille, France.ORCID 0000-0001-6534-3467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores the potential of natural bioactive peptides from animal venoms as targeted anti-cancer agents with reduced toxicity. Initially, we screened a broad collection of animal venoms for their antiproliferative activity against cancer cell lines. From this collection, we selected venoms from

Indexed as

Antineoplastic AgentsCell ProliferationCell SurvivalElapid VenomsGlioblastomaNajaPeptidesAnimalsApoptosisCell Line, TumorHumansAntineoplastic AgentsElapid VenomsPeptidesantiproliferative activityapoptosiscobra cytotoxinNaja anchietaeNaja senegalensisnecrosispeptidevenom

Identifiers

PMID39453209
PMCPMC11511367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.